Claim Check: Is 'The Pitt' Both a Critical and Crowd Favorite? The Evidence Says Yes.

The claim is that 'The Pitt,' the 2025 Max medical drama, is both a critical and crowd favorite. The evidence supports this verdict clearly and across multiple independent measurement systems.

The numbers are striking. According to Rotten Tomatoes, the show holds a 98% Tomatometer — meaning nearly every professional critic who reviewed it gave a positive assessment — alongside a 97% audience score, reflecting near-identical enthusiasm from general viewers. On Metacritic, which uses a weighted average of critic reviews rather than a simple approval percentage, 'The Pitt' earned an 88 out of 100, a threshold Metacritic classifies as 'universal acclaim.' These three figures come from two separate aggregators using different methodologies, and they all point in the same direction.

The strongest version of a skeptical counterargument would be that review aggregator scores can be gamed, inflated by early superfan voting, or based on a thin sample of reviews. That concern is worth taking seriously. However, the Metacritic score — which weights critics by outlet prestige and filters out outliers — reaching 88 makes the inflation argument hard to sustain. A padded audience score cannot move a curated critic metric like Metascore.

Commercial signals reinforce the critical data. According to a Warner Bros. Discovery press release, 'The Pitt' was one of Max's most-watched new series premieres. Variety reported in January 2025 that Max renewed the show for a second season shortly after its debut, explicitly citing strong audience demand and critical reception. Networks renew shows for business reasons, not sentiment — a swift second-season order is a concrete indicator that viewership held up under scrutiny.

The Hollywood Reporter's 2025 review praised the show as a 'gripping, well-acted medical drama,' contributing to the broad critical consensus. It is fair to concede that 'crowd favorite' is a relative term — the dossier does not provide raw viewership numbers that would allow a direct comparison to, say, the most-watched cable dramas of the decade. What the evidence does establish is that the audience response mirrors the critical response, which is precisely what the claim requires.

The manipulation pattern to watch for in entertainment claims is the selective citation of one metric while ignoring others — praising a high audience score while burying a poor critical one, or vice versa. This claim survives that test because both halves hold independently. When a show scores 98% with critics and 97% with audiences on Rotten Tomatoes while simultaneously earning an 88 Metascore and a rapid renewal, the 'critical- and crowd-favorite' label is not hype — it is a straightforward description of the data.